Emerging technologies are pivotal in healthcare. GSK's María Cardenal-Iradier, Jorge Pou, and Sergio Ostalé presented to the IDIS Foundation's Innovation Committee their proposals using AI to...
This year, one of the main headaches for managers in the sector will be inflation. GSK and Novartis plan to carry out a double-digit price increase...
Malaria remains the leading cause of childhood illness and death in sub-Saharan Africa, claiming the lives of over 260,000 African children under the age of five...
GSK, Lilly, and Vir Biotechnology have recently presented the results of a COVID-19 study. The two monoclonal antibodies in combination have demonstrated a 70% relative reduction...
GlaxoSmithKline is beefing up its pharmaceuticals business with the acquisition of Tesaro for its strength in cancer treatment drugs, and that’s just the beginning.